SPHK1 and hepatocellular carcinoma: HULC promotes tumor angiogenesis in liver cancer through miR-107/E2F1/SPHK1 signaling [23] and modulates abnormal lipid metabolism in hepatoma cells through a miR-9-mediated RXRA signaling pathway [24].